Dexcom makes continuous glucose monitoring systems that track blood sugar for people with diabetes and others. It last closed at $82.04 on Nov 17, up 0.53% on the day. DXCM reports earnings on Thu, Feb 11, 2027. The average 12-month price target from 8 analysts is $100.63 (+22.7% from the last close), with a high of $120.00 and a low of $85.00. Analyst consensus is Strong Buy, based on the latest ratings from 8 firms (7 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 9 whale options trades in DXCM, 67% of them bullish and 33% bearish. In the past 30 days there were 4 dark pool prints totaling $4.3M, the largest $2.5M.
Each firm's latest rating on DXCM in the past 90 days
Average 12-month target
$100.63
▲ 22.7% upside
Based on 8 analysts who set a price target on DXCM in the past 90 days. The average target is $100.63, with a high of $120.00 and a low of $85.00, compared with the last close of $82.04.
Low $85.00Avg $100.63High $120.00
Blue marker: last close $82.04
Highest target$120.00
Average target$100.63
Lowest target$85.00
Latest rating changes
UBSTarget raised
Oct 31Buy$96 → $107
Canaccord GenuityTarget raised
Oct 31Buy$90 → $97
JP MorganTarget raised
Oct 30Hold$82 → $85
BarclaysTarget raised
Oct 30Buy$115 → $120
StoneXMaintained
Oct 30Buy$93
Date
Firm
Action
Rating
Price target
Oct 31
UBS
Target raised
Buy
$96 → $107
Oct 31
Canaccord Genuity
Target raised
Buy
$90 → $97
Oct 30
JP Morgan
Target raised
Hold
$82 → $85
Oct 30
Barclays
Target raised
Buy
$115 → $120
Oct 30
StoneX
Maintained
Buy
$93
Loading…
Technical Analysis
DXCM · as of the Nov 17 close · updated after every close
Moving sideways
The stock sits between its 20 and 50 day averages. It is 8% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 49). The nearest support is the 20 day average at $81.21, and the nearest resistance the Pivot at $82.54.
Short trendNeutral
Long trendBullish
MomentumImproving
StretchNormal
VolatilityHigh, 3.5%/day
Key levels
$92.5952 week high+12.9%
$87.70Swing high (Oct 1)+6.9%
$84.1250 day average+2.5%
$83.52Pivot R1+1.8%
$82.82100 day average+1.0%
$82.54Pivot+0.6%
$82.04Last close
$81.2120 day average−1.0%
$81.06Pivot S1−1.2%
$78.93Swing low (Nov 11)−3.8%
$75.17200 day average−8.4%
$56.7252 week low−30.9%
Indicators
RSI (14)
48.84
Middle of its range
Neutral
MACD
-0.60
Above its signal line
Bullish
Stochastic
35.2
Middle of its range
Neutral
ADX (14)
15.4
No clear trend
Williams %R
-70.4
Oversold below −80, overbought above −20
Neutral
CCI (20)
36.6
Oversold below −100, overbought above 100
Neutral
Rate of change
−1.1%
Change over 10 sessions
Bearish
ATR (14)
$2.87
Typical daily range, 3.5% of price
MA 10Below
MA 20Above
MA 50Below
MA 100Below
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityNormal, 7.3%/day
Key levels
$92.5952 week high+12.9%
$87.70Swing high (Oct 1)+6.9%
$84.1250 day average+2.5%
$83.52Pivot R1+1.8%
$82.82100 day average+1.0%
$82.54Pivot+0.6%
$82.04Last close
$81.2120 day average−1.0%
$81.06Pivot S1−1.2%
$78.93Swing low (Nov 11)−3.8%
$75.17200 day average−8.4%
$56.7252 week low−30.9%
Indicators
RSI (14)
52.14
Middle of its range
Neutral
MACD
2.27
Below its signal line
Bearish
Stochastic
31.6
Middle of its range
Neutral
ADX (14)
19.9
No clear trend
Williams %R
-65.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
-18.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−1.2%
Change over 10 sessions
Bearish
ATR (14)
$6.00
Typical daily range, 7.3% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200–
What happened before, for DXCM
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how DXCM did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Whale flow leans bullish6 bullish and 3 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow DXCM usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How DXCM has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Oct 29, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DXCM is in one of them and how their past DXCM trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Dexcom
Dexcom is a medical device company based in San Diego, California. It designs, makes and sells continuous glucose monitoring systems, which are wearable sensors that track blood sugar without repeated finger sticks. Its main products include the G7 and G7 15 Day systems, the G6, the Dexcom ONE+ and Stelo, a glucose sensor sold without a prescription for adults with prediabetes or Type 2 diabetes who do not use insulin. Its customers include people with diabetes, their caregivers and clinicians, and makers of insulin pumps and pens.